Amicogen, Inc. (KOSDAQ:092040)

Amicogen Revenue

Amicogen had revenue of 12.28B KRW in the quarter ending March 31, 2026, with 13.49% growth. This brings the company's revenue in the last twelve months to 43.44B, down -71.09% year-over-year. In the year 2025, Amicogen had annual revenue of 41.98B, down -75.82%.

• Revenue (ttm): 43.44B
• Revenue Growth: -71.09%
• P/S Ratio: 2.06
• Revenue / Employee: 184.07M
• Employees: 236
• Market Cap: 89.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	41.98B	-131.62B	-75.82%
Dec 31, 2024	173.60B	13.70B	8.57%
Dec 31, 2023	159.90B	15.61B	10.82%
Dec 31, 2022	144.30B	19.41B	15.55%
Dec 31, 2021	124.88B	9.02B	7.79%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error